2012/3-4 GaBI Journal Table of Contents


Editor’s Letter

Latest features in GaBI Journal, 2012, issue 3-4

Letters to the Editor

A bioethicist’s view of the use of biosimilars

A clinician’s view of the ethics of the use of biosimilars


Generics policies–a globally-relevant implementation challenge

Reference price systems: stakeholder dialogue and involvement


Statin generics: no differences in efficacy after switching

Pharmacovigilance of biosimilars: challenges and possible solutions

Original Research

Saving money in the European healthcare systems with biosimilars

Review Article

Reference pricing systems in Europe: characteristics and consequences


Terminology for biosimilars–a confusing minefield

Health professionals in the risk communication process on counterfeit medicines

Special Report

The MEDICRIME Convention: criminalising the falsification of medicines and similar crimes


ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities

Conference Report

The potential of generics policies: more room for exploitation–PPRI Conference Report


Austria could save Euros 256 million by using more generics

Abstracted Scientific Content

The potential for doctors to contribute to biosimilar guidelines


Source URL: https://gabi-journal.net/20123-4-gabi-journal-table-of-contents.html

Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048